Computed tomography volumetry of esophageal cancer - the role of semiautomatic assessment
暂无分享,去创建一个
Michael A. Fischer | Torkel B. Brismar | Henrik Lehmann | Åse Johnsson | Yi-Hua Zhang | Ioannis Rouvelas | Gunnar Herlin | Lars Lundell | L. Lundell | Yi-Hua Zhang | T. Brismar | Å. Johnsson | M. Fischer | I. Rouvelas | G. Herlin | H. Lehmann
[1] B. Krause,et al. New trends for staging and therapy for localized gastroesophageal cancer: the role of PET. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.
[2] S. Leung,et al. Assessing chemotherapy response of squamous cell oesophageal carcinoma with spiral CT. , 1999, The British journal of radiology.
[3] Wolfgang Schröder,et al. Predicting response to neoadjuvant therapy in esophageal cancer , 2011, Expert review of anticancer therapy.
[4] C. Metreweli,et al. Oesophageal tumour volume measurement using spiral CT , 1996 .
[5] D. Low. Update on Staging and Surgical Treatment Options for Esophageal Cancer , 2011, Journal of Gastrointestinal Surgery.
[6] R. Cerfolio,et al. The accuracy of endoscopic ultrasonography with fine-needle aspiration, integrated positron emission tomography with computed tomography, and computed tomography in restaging patients with esophageal cancer after neoadjuvant chemoradiotherapy. , 2005, The Journal of thoracic and cardiovascular surgery.
[7] A Comparison of Repeatability and Usability of Semi-Automated Volume Segmentation Tools for Measurement of Vestibular Schwannomas. , 2018, Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology.
[8] K. Miles,et al. Tumour heterogeneity in oesophageal cancer assessed by CT texture analysis: preliminary evidence of an association with tumour metabolism, stage, and survival. , 2012, Clinical radiology.
[9] R. Reznek,et al. CT assessment of tumour response to treatment: comparison of linear, cross-sectional and volumetric measures of tumour size. , 2000, The British journal of radiology.
[10] A. Beckett,et al. AKUFO AND IBARAPA. , 1965, Lancet.
[11] J. Lagergren,et al. Survival after surgery for oesophageal cancer: a population-based study. , 2005, The Lancet. Oncology.
[12] A. Ba-Ssalamah,et al. Change in volume parameters induced by neoadjuvant chemotherapy provide accurate prediction of overall survival after resection in patients with oesophageal cancer , 2016, European Radiology.
[13] Wolfgang A Weber,et al. PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial. , 2007, The Lancet. Oncology.
[14] L. Lundell,et al. Texture analysis of computed tomography data using morphologic and metabolic delineation of esophageal cancer-relation to tumor type and neoadjuvant therapy response. , 2018, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.
[15] V. Goh,et al. Primary esophageal cancer: heterogeneity as potential prognostic biomarker in patients treated with definitive chemotherapy and radiation therapy. , 2013, Radiology.
[16] P. Bossuyt,et al. Accuracy and reproducibility of 3D-CT measurements for early response assessment of chemoradiotherapy in patients with oesophageal cancer. , 2011, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[17] D. Altman,et al. STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT , 1986, The Lancet.
[18] R. Munden,et al. Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer. , 2004, The Annals of thoracic surgery.
[19] Unbiased estimation of tumor regression rates during chemoradiotherapy for esophageal carcinoma using CT and stereology. , 2005, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.
[20] E. Rummeny,et al. Adenocarcinomas of esophagogastric junction: multi-detector row CT to evaluate early response to neoadjuvant chemotherapy. , 2006, Radiology.
[21] G. Sloof. Response monitoring of neoadjuvant therapy using CT, EUS, and FDG-PET. , 2006, Best practice & research. Clinical gastroenterology.
[22] J. Bosset,et al. Tumor Volume as Outcome Determinant in Patients Treated With Chemoradiation for Locally Advanced Esophageal Cancer , 2006, American journal of clinical oncology.
[23] S. Friesland,et al. A randomized clinical trial of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for cancer of the oesophagus or gastro-oesophageal junction. , 2016, Annals of oncology : official journal of the European Society for Medical Oncology.
[24] V Goh,et al. Assessment of changes in tumor heterogeneity following neoadjuvant chemotherapy in primary esophageal cancer. , 2015, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.
[25] L. Lundell,et al. Predictors of postoperative morbidity and mortality after surgery for gastro-oesophageal carcinomas. , 1995, The European journal of surgery = Acta chirurgica.
[26] J. Lagendijk,et al. Diffusion-weighted magnetic resonance imaging for the prediction of pathologic response to neoadjuvant chemoradiotherapy in esophageal cancer. , 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[27] G. Eslick,et al. Safety and efficacy of esophageal stents preceding or during neoadjuvant chemotherapy for esophageal cancer: a systematic review and meta-analysis. , 2014, Journal of gastrointestinal oncology.
[28] Dimitris Visvikis,et al. Characterization of PET/CT images using texture analysis: the past, the present… any future? , 2016, European Journal of Nuclear Medicine and Molecular Imaging.
[29] G. Peters,et al. Positron emission tomography using 2-deoxy-2-[18F]-fluoro-D-glucose for response monitoring in locally advanced gastroesophageal cancer; a comparison of different analytical methods. , 2003, Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging.
[30] S. Larson,et al. Positron emission tomography/computerized tomography functional imaging of esophageal and colorectal cancer. , 2004, Cancer journal.
[31] J. S. Kim,et al. Comparison of endoscopic ultrasonography (EUS), positron emission tomography (PET), and computed tomography (CT) in the preoperative locoregional staging of resectable esophageal cancer , 2009, Surgical Endoscopy.
[32] E Bellon,et al. Laryngeal tumor volume measurements determined with CT: a study on intra- and interobserver variability. , 1998, International journal of radiation oncology, biology, physics.
[33] B. Krause,et al. Curative treatment of oesophageal carcinoma: current options and future developments , 2011, Radiation oncology.
[34] C. Mariette,et al. Therapeutic strategies in oesophageal carcinoma: role of surgery and other modalities. , 2007, The Lancet. Oncology.
[35] Tian-wu Chen,et al. Intravoxel incoherent motion diffusion-weighted imaging of resectable oesophageal squamous cell carcinoma: association with tumour stage. , 2018, The British journal of radiology.
[36] F. Detterbeck,et al. Inadequacy of computed tomography in assessing patients with esophageal carcinoma after induction chemoradiotherapy , 1999, Cancer.
[37] I. B. Borel Rinkes,et al. International survey on esophageal cancer: part II staging and neoadjuvant therapy. , 2009, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.
[38] Vicky Goh,et al. The precision of textural analysis in 18F-FDG-PET scans of oesophageal cancer , 2015, European Radiology.
[39] F. Giganti,et al. Apparent diffusion coefficient modifications in assessing gastro-oesophageal cancer response to neoadjuvant treatment: comparison with tumour regression grade at histology , 2013, European Radiology.
[40] J. W. Beck,et al. Volume determinations using computed tomography. , 1982, AJR. American journal of roentgenology.